MarketFriction

Norris Medicines Ltd

BSE 524414 · Trading & Distributors
₹16.30 -4.96%
BSE close2026-10-01
Market cap₹18.0 Cr.

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales2.560.651.490.721.271.112.721.462.003.271.410.92
Expenses2.800.691.010.881.421.142.651.562.492.321.111.20
Operating Profit-0.24-0.040.48-0.16-0.15-0.030.07-0.10-0.490.950.30-0.28
OPM %-9.38%-6.15%32.21%-22.22%-11.81%-2.70%2.57%-6.85%-24.50%29.05%21.28%-30.43%
Other Income0.000.000.030.010.000.000.050.020.000.000.020.00
Interest0.090.090.110.080.080.120.150.110.110.130.150.00
Depreciation0.140.140.140.130.130.130.140.120.120.120.120.11
Profit before tax-0.47-0.270.26-0.36-0.36-0.28-0.17-0.31-0.720.700.05-0.39
Tax %0.00%0.00%34.62%0.00%0.00%0.00%35.29%0.00%0.00%0.00%0.00%0.00%
Net Profit-0.48-0.270.17-0.37-0.36-0.28-0.23-0.31-0.720.700.05-0.40
EPS in Rs-0.48-0.270.17-0.37-0.36-0.28-0.23-0.31-0.720.700.05-0.40
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales18.8620.4613.5716.267.8412.259.448.365.645.828.137.60
Expenses18.0320.4615.4916.8710.0014.009.527.435.816.087.477.12
Operating Profit0.830.00-1.92-0.61-2.16-1.75-0.080.93-0.17-0.260.660.48
OPM %4.40%0.00%-14.15%-3.75%-27.55%-14.29%-0.85%11.12%-3.01%-4.47%8.12%6.32%
Other Income0.300.060.140.040.090.050.030.010.010.060.050.02
Interest0.670.600.700.730.881.631.481.500.370.440.500.39
Depreciation0.600.650.710.710.730.670.660.630.570.540.490.47
Profit before tax-0.14-1.19-3.19-2.01-3.68-4.00-2.19-1.19-1.10-1.18-0.28-0.36
Tax %-128.57%-35.29%-21.00%-16.42%-22.83%24.25%49.32%47.06%8.18%5.08%0.00%
Net Profit0.04-0.77-2.51-1.68-2.84-4.96-3.26-1.75-1.19-1.24-0.28-0.37
EPS in Rs0.04-0.77-2.51-1.68-2.84-4.96-3.26-1.75-1.19-1.24-0.28-0.37
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth-8%-8%-1%16%
Compounded Profit Growth%14%23%69%
Stock Price CAGR%13%17%15%
Return on Equity%%%%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital9.939.939.939.939.939.939.939.939.939.939.939.93
Reserves-4.63-4.60-5.36-7.88-9.55-12.39-17.36-20.62-22.37-23.56-24.79-25.07
Borrowings8.167.517.577.7111.2417.9215.5221.0821.4021.5221.5821.53
Other Liabilities4.695.069.9010.928.765.1011.693.804.726.297.096.50
Total Liabilities18.1517.9022.0420.6820.3820.5619.7814.1913.6814.1813.8112.89
Fixed Assets8.618.349.979.328.908.257.677.076.475.795.274.79
CWIP0.000.000.000.000.000.000.000.000.000.000.000.00
Investments0.010.010.010.010.010.010.010.010.010.010.010.01
Other Assets9.539.5512.0611.3511.4712.3012.107.117.208.388.538.09
Total Assets18.1517.9022.0420.6820.3820.5619.7814.1913.6814.1813.8112.89
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-1.431.35-0.960.80-1.92-2.881.11-1.011.200.170.510.59
Cash from Investing Activity-0.88-0.34-2.05-0.08-0.290.00-0.06-0.09-0.020.050.00-0.09
Cash from Financing Activity0.10-1.323.16-0.662.182.86-1.091.10-1.18-0.20-0.50-0.52
Net Cash Flow-2.21-0.310.150.06-0.02-0.02-0.040.000.000.020.00-0.02
Free Cash Flow-2.301.03-3.240.74-2.21-2.961.02-1.071.170.260.490.58
CFO/OP-84%163%-42%315%133%-63%1,262%129%-100%-196%89%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days73.6653.6184.2066.4467.57128.4953.3342.1548.0368.6088.4352.53
Inventory Days100.05134.23129.50238.53134.81323.82212.99157.45347.62594.15436.94337.84
Days Payable111.6699.30125.29252.40139.83233.37218.8386.53149.91244.25320.57222.40
Cash Conversion Cycle62.0688.5488.4152.5662.55218.9447.49113.06245.73418.51204.80167.97
Working Capital Days27.7534.84-16.06-91.18-32.55-30.73-103.69-97.82-122.25-202.56-240.82-167.46
ROCE %4.02%4.03%-4.08%-22.92%-11.97%-20.68%-20.13%-7.68%3.20%-8.43%-10.13%3.36%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters34.01%34.01%34.01%34.01%34.01%34.00%34.00%34.00%34.00%34.00%34.01%34.01%
DIIs0.07%0.07%0.07%0.07%0.07%0.07%0.07%0.07%0.07%0.07%0.07%0.07%
Public65.91%65.91%65.91%65.90%65.91%65.92%65.93%65.93%65.92%65.92%65.90%65.90%
No. of Shareholders25,24225,31725,51725,40025,49825,65925,81525,95025,89525,79125,77725,777

Fundamentals

Market Cap₹ 18.0 Cr.
Current Price₹ 18.0
Book Value₹ -15.1
ROCE3.36 %
ROE%
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)16%
Compounded Profit Growth (TTM)69%
Standalone figures.
Valuation
Market capRs 16 Cr
Enterprise valueRs 38 Cr
Price to book-1.08x
Price to sales2.14x
EV / EBITDA61.99x
EV / EBIT270.08x
EV / sales4.98x
Price to cash flow27.63x
Earnings yield-2.27%
P/B, 3-year average-1.00x
P/B, 5-year average-1.42x
Profitability
Operating margin (excl. other income)8.12%
Operating margin (incl. other income)8.73%
EBITDA margin8.03%
Pre-tax margin-4.74%
Net profit margin-4.87%
Net margin, latest quarter-43.48%
ROE1.87%
ROCE3.36%
ROA-2.10%
ROE, 3-year average6.57%
ROCE, 3-year average-5.15%
ROA, 3-year average-6.50%
ROE, 5-year average14.16%
ROCE, 5-year average-3.98%
ROA, 5-year average-10.25%
ROIC (approx.)2.20%
Other income / net worth-0.33%
Growth
Sales growth (latest year)39.69%
Sales CAGR, 3 years-0.93%
Sales CAGR, 5 years-7.87%
Sales growth QoQ-34.75%
Profit growth QoQ-900.00%
Sales growth YoY (latest quarter)-36.99%
Per share
EPS (TTM)Rs -0.37
EPS (latest year)Rs -0.28
EPS (latest quarter)Rs -0.40
EPS, 3-year averageRs -0.90
EPS, 5-year averageRs -1.54
Book value per shareRs -15.14
Sales per shareRs 7.60
Cash flow per shareRs 0.59
Free cash flow per shareRs 0.58
Efficiency
Asset turnover0.63x
Fixed asset turnover1.70x
Inventory turnover1.30x
Inventory days281 days
Debtor days53 days
Debtors turnover6.95x
Creditor days222 days
Cash conversion cycle168 days
Working capital days-167 days
Leverage
Total debtRs 22 Cr
Cash and bankRs 0 Cr
Net debtRs 22 Cr
Debt to equity-1.42x
Net debt / EBITDA35.26x
Interest coverage0.28x
Owners' fund to total sources-117.46%
Debt to assets167.03%
Cash flow
Cash from Operating Activity (latest year)Rs 1 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs -1 Cr
Net Cash Flow (latest year)Rs -0 Cr
Free cash flow (latest year)Rs 1 Cr
FCFE (approx.: FCF + change in debt)Rs 1 Cr
Sales to cash flow13.78x
Statement figures
Net sales (TTM)Rs 8 Cr
Net sales (latest year)Rs 8 Cr
Sales (latest quarter)Rs 1 Cr
Operating profit excl. other income (latest year)Rs 1 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 1 Cr
PBDT (TTM)Rs 0 Cr
Profit before tax (TTM)Rs -0 Cr
Net profit (TTM)Rs -0 Cr
Net profit (latest year)Rs -0 Cr
Net profit (latest quarter)Rs -0 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 5 Cr
Total expenditure (latest year)Rs 7 Cr
Total income (latest year)Rs 8 Cr
Share capitalRs 10 Cr
ReservesRs -25 Cr
Shareholders' fundsRs -15 Cr
Total assetsRs 13 Cr
Net blockRs 5 Cr
InvestmentsRs 0 Cr
ReceivablesRs 1 Cr
InventoryRs 4 Cr
Other liabilitiesRs 6 Cr
Shares outstanding (crore)1.00
Ownership
Promoter holding34.01% (+0.01 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Period524414Nifty 50Difference
1 week-17.1%-2.8% -14.4 pts
1 month+4.2%-6.8% +11.0 pts
3 months+20.2%-7.6% +27.8 pts
3 years+35.8%+14.2% +21.7 pts
5 years+62.8%+27.9% +34.9 pts

Red flags

F-score 6 of 8
seriousNegative equity Shareholders' equity is negative
lookRepeated losses Net loss in each of the last two years
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹1 Cr -37.0% vs Jun 2025. Net loss ₹0 Cr.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Redington Ltd31,69717.618.4 %
MMTC Ltd8,51442.38.67 %
MSTC Ltd5,02821.530.3 %
BN Agrochem Ltd1,8981114.44 %
Creative Newtech Ltd1,64622.318.8 %
Pervasive Commodities Ltd1,04922.1 %
RRP Defense Ltd843-11.1 %
Yamuna Syndicate Ltd7848.564.17 %
Shiv Aum Steels Ltd74277.98.20 %
State Trading Corporation of India Ltd64413.3%
Arvaya Healthcare Ltd600451%
SMT Engineering Ltd59624.325.4 %
HP Telecom India Ltd52820.719.9 %
Riddhi Siddhi Gluco Biols Ltd52737.22.74 %
Oswal Agro Mills Ltd4742.03 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Norris Medicines Ltd?

Norris Medicines Ltd (524414) has a market capitalisation of Rs 18.0 Cr. at the 2026-10-01 close.

What were Norris Medicines Ltd's latest quarterly results?

In the Jun 2026 quarter, Norris Medicines Ltd sales was Rs 1 Cr (-37.0% vs Jun 2025) with a net loss of Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03